LPL Financial’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.9K | Buy |
11,269
+413
| +4% | +$2.64K | ﹤0.01% | 5167 |
|
|
2025
Q1 | $52.8K | Sell |
10,856
-4,264
| -28% | -$20.7K | ﹤0.01% | 5019 |
|
|
2024
Q4 | $145K | Buy |
15,120
+3,875
| +34% | +$37K | ﹤0.01% | 4785 |
|
|
2024
Q3 | $93.9K | Buy |
+11,245
| New | +$93.9K | ﹤0.01% | 4800 |
|
|
2024
Q1 | – | Sell |
-10,663
| Closed | -$25.6K | – | 4868 |
|
|
2023
Q4 | $25.6K | Buy |
+10,663
| New | +$25.6K | ﹤0.01% | 4652 |
|
|
2021
Q4 | – | Sell |
-4,541
| Closed | -$227K | – | 4355 |
|
|
2021
Q3 | $227K | Buy |
4,541
+337
| +8% | +$16.8K | ﹤0.01% | 3841 |
|
|
2021
Q2 | $265K | Sell |
4,204
-2,000
| -32% | -$126K | ﹤0.01% | 3664 |
|
|
2021
Q1 | $576K | Sell |
6,204
-5,988
| -49% | -$556K | ﹤0.01% | 2893 |
|
|
2020
Q4 | $1.09M | Sell |
12,192
-1,294
| -10% | -$116K | ﹤0.01% | 2102 |
|
|
2020
Q3 | $1.39M | Buy |
13,486
+7,021
| +109% | +$726K | ﹤0.01% | 1676 |
|
|
2020
Q2 | $511K | Buy |
+6,465
| New | +$511K | ﹤0.01% | 2352 |
|
|
2019
Q1 | – | Sell |
-6,590
| Closed | -$391K | – | 3183 |
|
|
2018
Q4 | $391K | Buy |
+6,590
| New | +$391K | ﹤0.01% | 2233 |
|
|
2015
Q3 | – | Sell |
-8,572
| Closed | -$282K | – | 2811 |
|
|
2015
Q2 | $282K | Buy |
+8,572
| New | +$282K | ﹤0.01% | 2356 |
|